ReCode Therapeutics
Powering the future of genetic medicines through superior delivery
United States · $281.0M raised
- Business Model
- B2B
- Website
- recodetx.com
- Total Funding
- $281.0M
- Last Round
- $29.0M Venture RoundJan 2024
- Rounds
- 5
About
Clinical-stage genetic medicines company using precision delivery to advance mRNA and gene correction therapeutics.
Summary
ReCode Therapeutics is a Biotech company based in United States. It has raised $281.0M in total across 5 rounds, most recently a $29.0M Venture Round round in Jan 2024. Investors include Cystic Fibrosis Foundation, Bioluminescence Ventures and Amgen.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...